دورية أكاديمية

A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

التفاصيل البيبلوغرافية
العنوان: A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)
المؤلفون: Spiliopoulou, PavlinaAff1, Aff2, Kazmi, Farasat, Aroldi, Francesca, Holmes, Thomas, Thompson, David, Griffiths, Lucinda, Qi, Cathy, Parkes, Matthew, Lord, Simon, Veal, Gareth J., Harrison, David J.Aff7, Aff8, Coyle, Vicky M., Graham, Jill, Jeffry Evans, Thomas R.Aff1, Aff2, Blagden, Sarah P.Aff3, Aff4, Aff10, IDs13046024030101_cor15
المصدر: Journal of Experimental & Clinical Cancer Research. 43(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17569966
DOI:10.1186/s13046-024-03010-1